echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Chemicals Industry > Rubber Plastic News > Mitsubishi considers building a 350,000-ton/year ethylene-based MMA plant in the United States

    Mitsubishi considers building a 350,000-ton/year ethylene-based MMA plant in the United States

    • Last Update: 2022-08-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Mitsubishi Chemical Corporation (MCC) is studying the feasibility of a new methyl methacrylate (MMA) plant using the company's Alpha technology, using ethylene instead of acetone as a feedstock


    .


    The Louisiana Economic Development Association said on Tuesday (8th) that the final investment decision for the project is expected to be made in mid-2022, with an estimated capacity of 350,000 tons


    .


    The proposed complex will be built on 67 acres (27 hectares) of green space that Mitsubishi acquired from synthetic rubber maker Lion Elastomers


    .


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.